<p>Samples of NHS (50 μL) were incubated with the bristles extract (175 μg/mL) or PBS, in the presence or absence of 10 mM 1,10-Phenanthroline (Phen), at 37°C for 30 min, and SC5b-9 complex present in human serum samples was measured using the MicroVue SC5b-9 Plus EIA Kit. Data are representative for two separate experiments, performed in duplicate, and the results are expressed as concentration of SC5b-9 complex per mL of human serum (ng/mL) ± SD. (***) <i>p</i> < 0.001: significant differences between the mean values obtained with the buffer and between the treatments.</p
Summary. The dynamics of human complement consumption by immune complexes (ICs) was studied. ICs wer...
C activation was inhibited in subjects’ sera by EDTA. Sera were then supplemented with classical C5-...
<p>For measuring the background, classical, lectin & alternative and only alternative pathway activa...
<p><b>[A]</b> Samples (50 μL) of normal human serum (NHS) were pre-incubated with increasing concent...
<p>Samples of NHS (50 μL) were incubated with the bristles extract (175 μg/mL) or PBS, in the presen...
<p>Samples of 3 μg of the extract or 0.1 μg of Ps82 were incubated, in the absence or presence of 10...
<p>Samples (50 μL) of normal human serum (NHS) were pre-incubated with 0.25, 0.33 or 0.5 μg/mL of Ps...
<p>Samples of NHS (50 μL) were incubated with Ps82 (0.33 μg/mL) or the <i>Premolis semirufa’s</i> br...
<p>Samples of the bristles extract (2.0 μg for C3 and C4 or 3.0 μg for C5) were incubated, in the ab...
<p><b>[A]</b> Chromatography of 1 mg of the extract on a FPLC-GP-250 Plus system using a molecular e...
Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. Blood ...
Subjects’ sera were supplemented with purified C5 (commercial) to physiological concentration. C act...
C was activated in-vitro via the CP by aggregated IgG (A) or via the AP by Zymosan (B) and levels of...
’s bristles extract could interfere with the human complement system. bristles extract. The protease...
<p>Microtiter plates were coated with various purified human complement proteins or BSA as a negativ...
Summary. The dynamics of human complement consumption by immune complexes (ICs) was studied. ICs wer...
C activation was inhibited in subjects’ sera by EDTA. Sera were then supplemented with classical C5-...
<p>For measuring the background, classical, lectin & alternative and only alternative pathway activa...
<p><b>[A]</b> Samples (50 μL) of normal human serum (NHS) were pre-incubated with increasing concent...
<p>Samples of NHS (50 μL) were incubated with the bristles extract (175 μg/mL) or PBS, in the presen...
<p>Samples of 3 μg of the extract or 0.1 μg of Ps82 were incubated, in the absence or presence of 10...
<p>Samples (50 μL) of normal human serum (NHS) were pre-incubated with 0.25, 0.33 or 0.5 μg/mL of Ps...
<p>Samples of NHS (50 μL) were incubated with Ps82 (0.33 μg/mL) or the <i>Premolis semirufa’s</i> br...
<p>Samples of the bristles extract (2.0 μg for C3 and C4 or 3.0 μg for C5) were incubated, in the ab...
<p><b>[A]</b> Chromatography of 1 mg of the extract on a FPLC-GP-250 Plus system using a molecular e...
Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. Blood ...
Subjects’ sera were supplemented with purified C5 (commercial) to physiological concentration. C act...
C was activated in-vitro via the CP by aggregated IgG (A) or via the AP by Zymosan (B) and levels of...
’s bristles extract could interfere with the human complement system. bristles extract. The protease...
<p>Microtiter plates were coated with various purified human complement proteins or BSA as a negativ...
Summary. The dynamics of human complement consumption by immune complexes (ICs) was studied. ICs wer...
C activation was inhibited in subjects’ sera by EDTA. Sera were then supplemented with classical C5-...
<p>For measuring the background, classical, lectin & alternative and only alternative pathway activa...